Patents by Inventor Hao-Chia Chen

Hao-Chia Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250035730
    Abstract: A current sensing calibration method includes setting a first calibration current, inputting the first calibration current to a current sensing circuit for detecting a first real digital code, acquiring offset calibration data according to the first real digital code and a first ideal digital code corresponding to the first calibration current, setting a second calibration current and a third calibration current, inputting the second calibration current to the current sensing circuit for detecting a second real digital code, inputting the third calibration current to the current sensing circuit for detecting a third real digital code, acquiring gain calibration data according to the second real digital code, the third real digital code, a second ideal digital code, and a third ideal digital code, and acquiring channel temperature calibration data after the current sensing circuit is calibrated according to the offset calibration data and the gain calibration data.
    Type: Application
    Filed: February 20, 2024
    Publication date: January 30, 2025
    Applicant: HIMAX TECHNOLOGIES LIMITED
    Inventors: Te-Chieh Kung, Ming-Chia Chen, Hugo Cruz, Hao-Wei Lin
  • Patent number: 5532214
    Abstract: A new protein, termed TAP 29, obtainable from the root tuber of the plant Trichosanthes kirilowii or produced by recombinant means is useful for treating HIV infections or tumors. In treating HIV infections, the protein is administered alone or in conjunction with conventional AIDS therapies. Also provided are processes for purifying the protein, DNA sequences encoding the protein, hosts expressing the protein, recombinant DNA methods for expressing the protein, and antibodies specific for the protein.
    Type: Grant
    Filed: July 14, 1994
    Date of Patent: July 2, 1996
    Assignees: New York University, American Biosciences, Inc., The United States of America as represented by the Department of Health and Human Services
    Inventors: Sylvia Lee-Huang, Philip L. Huang, Hao-chia Chen, Hsiang-fu Kung, Peter Huang, Henry I. Huang, Paul L. Huang
  • Patent number: 5484889
    Abstract: A protein, in particular MAP 30, obtainable from both the fruit and seeds of Momordica charantia or produced by recombinant means useful for treating tumors and HIV infections is disclosed. In treating HIV infections, the protein is administered alone or in conjunction with conventional AIDS therapies. Also provided are processes for purifying the protein, DNA sequences encoding the protein, and recombinant DNA methods for expressing the protein.
    Type: Grant
    Filed: July 21, 1994
    Date of Patent: January 16, 1996
    Assignees: New York University, American Biosciences, Inc., The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Sylvia Lee-Huang, Philip L. Huang, Peter L. Nara, Hao-Chia Chen, Hsiang-fu Kung, Peter Huang, Henry I. Huang, Paul L. Huang
  • Patent number: 5317009
    Abstract: New proteins, termed GAP 31, obtainable from the seeds of Gelonium multiflorum, and DAP 30 and DAP 32, obtainable from the leaves or seeds of Dianthus caryophyllus, or the above proteins produced by recombinant means, are useful for treating HIV infections. In treating HIV infections, the protein is administered alone or in conjunction with other anti-HIV therapeutics. Also provided are processes for purifying the proteins, DNA sequences encoding the proteins, hosts expressing the proteins, recombinant DNA methods for expressing the proteins, and antibodies specific for the proteins.
    Type: Grant
    Filed: August 26, 1991
    Date of Patent: May 31, 1994
    Assignees: New York University, American Biosciences, Inc., National Institutes of Health
    Inventors: Sylvia Lee-Huang, Hsiang-fu Kung, Paul L. Huang, Philip L. Huang, Peter Huang, Henry I. Huang, Hao-chia Chen
  • Patent number: 5221732
    Abstract: Peptides which exhibit improved broad spectrum antimicrobial activity are designed and synthesized based on the peptide sequences of magainin or PGS peptides. The modified peptide analogues are synthesized by replacing low helical potential amino acid residues with high helical potential residues and modifying the two termini in order to enhance the amphiphilic structures as well as to prolong antimicrobial activity by lowering their susceptibility to protease degradation. For example, low propensity residues within a strategic region of magainin II, e.g. Ser.sup.8, Gly.sup.13 and Gly.sup.18 are modified with Ala which is known to have high propensity. Amidation of Ser.sup.23, and acylation of Gly.sup.1 with acetyl or beta-alanyl and substitution of Gly.sup.1 with beta-alanine are carried out in order to lower the susceptibility to exopeptidase action.
    Type: Grant
    Filed: December 6, 1988
    Date of Patent: June 22, 1993
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Hao-Chia Chen, Judith H. Brown, John L. Morell, Charng-Ming Huang
  • Patent number: 4468383
    Abstract: The compounds of the invention are symmetrical dimers of enkephalin polypeptides comprising enkephalin polypeptide monomers linked at the C-termini thereof with a difunctional amino bridging group. The compounds are useful as investigative tools for probing the opiate receptor membranes, particularly as radiolabelled ligands for exploring the delta opiate receptor, and also have particular use as narcotic and/or analgesic agents.
    Type: Grant
    Filed: September 29, 1982
    Date of Patent: August 28, 1984
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Service
    Inventors: David Rodbard, Y. Shimohigashi, Hao-Chia Chen, Tommaso Costa